SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,781.89 -251.89
( -0.34%)

Global Indices

Nasdaq

51,707.15 -164.40
(-0.32%)

Dow Jones

7,828.98 0.74
(0.01%)

Hang Seng

67,780.30 2.78
(0.00%)

Nikkei 225

10,730.66 80.33
(0.75%)

Forex

USD-INR

95.69 -0.76
(-0.79%)

EUR-INR

107.00 -1.04
(-0.96%)

GBP-INR

126.57 -1.05
(-0.82%)

JPY-INR

0.60 -0.01
(-0.89%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

501.202063

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

17.37

15489.42

EPS(TTM)

Face Value()

Div & Yield %

45.47

0.58

Back

Tiaan Consumer reports standalone net loss of Rs 0.04 crore in the June 2026 quarter

Aug 12,2026

Net loss of Tiaan Consumer reported to Rs 0.04 crore in the quarter ended June 2026 as against net profit of Rs 0.05 crore during the previous quarter ended June 2025. Sales declined 40.00% to Rs 0.03 crore in the quarter ended June 2026 as against Rs 0.05 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	0.03	0.05	-40
OPM %	-133.33	100.00	-
PBDT	-0.04	0.05	PL
PBT	-0.04	0.05	PL
NP	-0.04	0.05	PL

72,781.89 -251.89 ( -0.34%)

51,707.15 -164.40 (-0.32%)

7,828.98 0.74 (0.01%)

67,780.30 2.78 (0.00%)

10,730.66 80.33 (0.75%)

95.69 -0.76 (-0.79%)

107.00 -1.04 (-0.96%)

126.57 -1.05 (-0.82%)

0.60 -0.01 (-0.89%)